Meeting Overview - The fourth meeting of the Supervisory Board of Guangdong Tianyuan Industrial Group Co., Ltd. was held on August 18, 2025, via telephone, email, and SMS notifications to all supervisors [1] - The meeting was chaired by Ms. Wang Qunfang, the chairperson of the Supervisory Board, and complied with relevant laws and regulations [1] Resolutions Passed - The Supervisory Board approved the company's 2025 semi-annual report and summary, confirming that the report accurately reflects the company's actual situation without any false records or misleading statements [2] - The voting results for the approval were unanimous, with 3 votes in favor and no opposition or abstentions [2] Fund Management - The Supervisory Board reviewed the special report on the actual storage and use of raised funds for the first half of 2025, concluding that the company disclosed information timely and accurately, adhering to regulations [2] - The board confirmed that there were no violations regarding the use of raised funds, ensuring that shareholder interests, especially those of minority shareholders, were protected [2] Project Delays - The board approved the postponement of certain fundraising project timelines, clarifying that this does not affect the project's implementation or funding purposes [3] - The decision was also unanimously supported, with 3 votes in favor [3] Foreign Exchange Risk Management - The Supervisory Board approved the company's plan to engage in foreign exchange forward settlement and sales, aimed at mitigating foreign exchange market risks [4] - The board emphasized that this activity is for hedging purposes and not for speculative trading, ensuring that it aligns with the company's long-term interests [4] Audit Firm Appointment - The Supervisory Board agreed to reappoint Huaxing Accounting Firm as the auditing agency for the year 2025, citing their experience and capability in providing fair audit services [5] - The decision also received unanimous support, with 3 votes in favor [5]

Core Points - The company, Suzhou Kaiweite Semiconductor Co., Ltd., has reported on the status of its fundraising activities and the use of raised funds as of June 30, 2025, following its initial public offering (IPO) [1][2][4] - The total amount raised from the IPO was approximately RMB 752.13 million, with a net amount of RMB 664.80 million after deducting issuance costs [1][2] - As of the reporting date, the company has utilized RMB 432.69 million of the raised funds, with RMB 166.04 million remaining in cash management [1][2][3] Fundraising Overview - The actual fundraising amount was RMB 752,131,593.99, with issuance costs totaling RMB 87,332,672.09, resulting in a net amount of RMB 664,798,921.90 [1] - The funds were fully received by August 14, 2023, and verified by an accounting firm [1] - The company has used RMB 432,686,824.30 of the raised funds by June 30, 2025, with specific allocations to various projects [1][2] Fund Utilization and Management - The company has not used any idle funds for temporary working capital during the reporting period [2][3] - A total of RMB 14,953,509.36 was earned from interest and cash management, with RMB 3,229,401.32 from deposit interest and RMB 11,724,108.04 from financial products [1][2] - The company has established a dedicated account for managing the raised funds, ensuring compliance with regulations [1][2][3] Project Status and Adjustments - The company has decided to postpone the expected operational status dates for several projects, including the "Intelligent Power Semiconductor R&D Upgrade Project" and "SiC Power Device R&D Upgrade Project," from March 2025 to March 2028 [6][7] - This decision was made to adapt to market conditions and ensure the efficient use of funds while maintaining project integrity [6][7] - The company has not changed the investment direction, implementation主体, or investment scale of the projects despite the postponement [7] Other Fund Usage - The company has approved a plan to repurchase shares using excess funds, with a total repurchase amount not exceeding RMB 20 million [2][3][7] - The repurchase will be conducted through the Shanghai Stock Exchange, with a maximum price of RMB 57.66 per share [2][3] - The company has maintained strict compliance with regulations regarding the use and disclosure of raised funds, ensuring no violations occurred [4][5]

Core Viewpoint - The company reported a revenue of 72.09 million yuan for the first half of 2025, marking a year-on-year increase of 20.85%, driven by growth in cytokine product sales and expansion into overseas markets. However, it also experienced a net loss of 24.22 million yuan, which is a 172% increase in losses compared to the previous year, primarily due to high R&D expenditures and a reduction in government subsidies [1][1][1] Financial Performance - Revenue for the first half of 2025 reached 72.09 million yuan, reflecting a 20.85% year-on-year growth [1] - Net profit loss amounted to 24.22 million yuan, which is a 172% increase in losses compared to the same period last year [1] - R&D expenses were 26.10 million yuan, accounting for 36.21% of total revenue [1] - Operating cash flow was negative at -14.08 million yuan, influenced by reduced sales collections and a decrease in subsidies [1] Project Updates - The completion of the fundraising projects "Core Raw Materials for Diagnosis and Innovative Diagnostic Reagents Industrialization Project" and "R&D Center Construction Project" has been postponed from September 2025 to September 2026 [1] - The location for the R&D center has been changed from Jinshan, Shanghai to Pudong New District, and the implementing entity has shifted from the subsidiary Chuangji Medical to Nearshore Technology [1] - The company stated that the postponement does not alter the investment content or total amount, and the adjustments were made based on a principle of prudence [1] Share Buyback Plan - The company approved a share buyback plan in October 2024, allowing for the repurchase of shares worth between 10 million to 20 million yuan using its own funds [1] - As of July 31, 2025, the company has not yet initiated the stock buyback [1]

Summary of Key Points Core Viewpoint The report provides a detailed account of the fundraising activities and the management of raised funds by Wuxi Dekeli Optoelectronic Technology Co., Ltd. It outlines the amounts raised, their usage, and compliance with regulatory requirements. Group 1: Fundraising Overview - The company raised a total of RMB 1,179,763,200.00 from its initial public offering (IPO) by issuing 24,320,000 shares at a price of RMB 48.51 per share, with a net amount of RMB 1,094,353,980.82 after deducting issuance costs [1][2] - In a subsequent offering, the company raised RMB 219,999,973.71 by issuing 3,464,021 shares at RMB 63.51 each, resulting in a net amount of RMB 217,149,951.88 after fees [2][30] Group 2: Fund Usage and Balances - As of June 30, 2025, the company has utilized RMB 526,762,655.47 from the IPO funds, leaving a balance of RMB 633,887,328.35 [2][3] - From the funds raised through the simplified procedure, RMB 105,386,112.54 has been used, with a remaining balance of RMB 117,280,466.63 [3] Group 3: Fund Management and Compliance - The company has established a fundraising management system in compliance with relevant laws and regulations, ensuring that funds are stored in dedicated accounts [4][31] - A tripartite agreement has been signed with the sponsor and the bank to regulate the management of the funds, ensuring investor protection [5][22] - The company has confirmed that there are no violations in the use of raised funds and has adhered to all disclosure requirements [17][37] Group 4: Cash Management - The company has approved the use of idle funds for cash management, allowing for investments in low-risk financial products, with a maximum of RMB 700 million allocated for such purposes [10][12] - As of June 30, 2025, the company had RMB 190 million in cash management products [12] Group 5: Project Implementation and Adjustments - There have been no changes in the implementation location or methods for the fundraising projects during the reporting period [13][16] - The company has approved extensions for certain fundraising project timelines, specifically for the "High-Speed Optical Module Production Line Expansion and Upgrade Project" [14]

Core Viewpoint - The supervisory board of Jiangsu Longda Superalloy Co., Ltd. has approved several key proposals during its 11th meeting, including the review of the 2025 semi-annual report and the use of idle funds, indicating a commitment to transparency and compliance with regulations [1][2][3][4][5][6][7][8] Group 1: Meeting Overview - The supervisory board meeting was held in person, with all members present and the procedures compliant with relevant laws and regulations [1] - The meeting's resolutions were deemed legally valid and were passed unanimously with no votes against or abstentions [2] Group 2: Financial Reports and Fund Management - The 2025 semi-annual report was approved, confirming that it accurately reflects the company's financial status and operational results [1][2] - The special report on the storage and use of raised funds was also approved, affirming compliance with regulatory requirements and proper use of funds [2][3] - The board agreed to temporarily use part of the idle raised funds to supplement working capital, enhancing fund efficiency and reducing financial costs [3][4] Group 3: Fund Utilization and Debt Management - The proposal to use part of the over-raised funds for permanent working capital supplementation and bank loan repayment was approved, ensuring no harm to shareholder interests [4][5] - The supervisory board also approved the registration of debt financing tools with a total amount not exceeding RMB 1 billion, aimed at improving liquidity management [5] Group 4: Profit Distribution and Project Adjustments - The profit distribution plan for the first half of 2025 was approved, aligning with legal requirements and considering the company's operational needs [6] - The board agreed to postpone certain fundraising project timelines, which aligns with the company's strategic planning and resource optimization [6][7] Group 5: Related Transactions - The board approved a proposal for signing a lease agreement, confirming that the transaction is fair and does not harm the company's or shareholders' interests [7][8]

Fundraising Overview - The company successfully raised a total of RMB 912.58 million by issuing 22.15 million shares at a price of RMB 41.20 per share, with a net amount of RMB 824.83 million after deducting issuance costs [2][10][17]. - As of June 30, 2025, the company has invested RMB 538.95 million in fundraising projects, with a remaining balance of RMB 322.63 million [2][4]. Fund Management and Usage - The company has established a fundraising management system to ensure the proper use and storage of raised funds, including signing a tripartite supervision agreement with the underwriter and banks [3][4]. - The company has utilized RMB 40 million of idle funds for cash management, generating a return of RMB 1.86 million, with RMB 29 million still invested in financial products [8][10]. Project Adjustments - The company has merged and adjusted its fundraising projects, increasing the total investment to RMB 696.39 million, with RMB 410.81 million sourced from excess funds [10][19]. - The completion dates for key projects have been postponed to March 2026 for the "20,000 tons of energy-saving motor magnetic tiles and 2,000 tons of high-performance neodymium iron boron steel construction project" and December 2026 for the "R&D center and auxiliary facilities construction project" [22][28]. Compliance and Oversight - The company has adhered to relevant laws and regulations regarding fundraising and project management, with no significant violations reported [13][30]. - The board of directors and supervisory board have approved the project delays, confirming that these changes do not affect the overall investment direction or harm shareholder interests [30][31].

Summary of Key Points Core Viewpoint - The company, Shandong Nanshan Zhishang Technology Co., Ltd., has decided to postpone the completion date of its fundraising project, specifically the "Annual Production of 80,000 Tons of High-Performance Differentiated Nylon Filament Project," to December 31, 2025, while maintaining the project's investment scope and purpose unchanged [4][6]. Group 1: Fundraising Overview - The company successfully issued 71,428,571 shares at a price of 14.00 RMB per share, raising a total of approximately 1 billion RMB, with a net amount of about 988 million RMB after deducting issuance costs [2][3]. - The funds raised have been deposited into a special account, and a tripartite supervision agreement has been signed with the sponsor and the bank [2]. Group 2: Fund Usage Status - As of June 30, 2025, the company has made progress in utilizing the raised funds for the project, although specific amounts and percentages are not detailed in the provided text [3][4]. Group 3: Reasons for Postponement - The postponement is attributed to several factors: 1. The funds were only available in mid-May 2025, affecting the payment and construction progress [5][6]. 2. The new product requires customer validation, delaying equipment acceptance and full production [6]. 3. The reliance on imported equipment has complicated on-site problem resolution [6]. 4. Structural changes in civil engineering have extended the construction period [6]. Group 4: Impact of Postponement - The postponement is a cautious decision that does not alter the project's implementation subject, purpose, or investment scale, and it is not expected to significantly impact the company's current operations [6][7]. Group 5: Review Procedures - The company's board and supervisory committee have reviewed and approved the postponement, confirming that it complies with relevant regulations and does not harm shareholder interests [7][8].

Core Viewpoint - The company has decided to postpone the expected completion dates for certain fundraising projects while maintaining the original investment purposes and project scales, ensuring no substantial impact on the implementation of these projects [1][4][5] Fundraising Overview - The company raised a total of RMB 186,122.39 million by issuing 14,785,700 shares at a price of RMB 125.88 per share, with a net amount of RMB 166,635.87 million after deducting issuance costs of RMB 19,486.52 million [1][2] - As of June 30, 2025, the cumulative investment in the fundraising projects is RMB 71,130.89 million, representing 42.69% of the total planned investment [2] Postponement Details - The postponement affects the "Intelligent Measurement and Control Equipment Production Base Project" and the "Research and Development Center Project," with adjustments made to the expected completion dates while keeping the project details unchanged [3][4] - The delays are attributed to various uncontrollable factors such as renovation progress, procurement of production and research equipment, and project timelines [3] Measures for Completion - The company will adhere to relevant regulations and enhance supervision over the use of raised funds to ensure legal and effective utilization [4] - The company plans to monitor project progress closely, optimize resource allocation, and manage the subsequent construction of the projects to ensure timely completion [4] Impact of Postponement - The postponement is a cautious decision based on the actual implementation status of the projects and does not alter the investment purposes or project scales, thus not significantly affecting the company's normal operations [4][5] - The supervisory board and the sponsoring institution have both agreed that the postponement will not harm shareholder interests or violate any regulations [5][6]

Core Viewpoint - The company has completed certain fundraising projects and plans to permanently supplement its working capital with the surplus funds, while also delaying some fundraising projects [1][4][7] Fundraising Basic Situation - The company raised a total of RMB 530 million through a private placement of 7.7046 million shares at a price of RMB 68.79 per share, with net proceeds amounting to RMB 524.83 million after deducting issuance costs [1][2] Fundraising Investment Projects - The total investment amount for the projects is RMB 314.44 million, with cumulative investment reaching RMB 524.51 million, resulting in a progress rate of 59.95% [3] - The actual investment amount for working capital is RMB 85.26 million, exceeding the planned investment due to income from bank financial products and interest from current deposits [3] Surplus Fund Usage and Reasons - The surplus funds will be permanently used to supplement working capital, enhancing the company's cash flow and economic efficiency [4] - The surplus is attributed to effective cost control and resource optimization during project implementation, as well as income generated from cash management of idle funds [3][4] Project Delay Details - The project "Technology Reserve Fund" has its expected completion date extended from August 2025 to August 2027 due to changes in market demand and the need for adjustments in key technology development [5][6] - The decision to delay is based on the company's strategic needs and aims to enhance core technology capabilities and long-term competitiveness [5][6] Approval Process - The board of directors approved the proposal regarding the completion of certain fundraising projects and the use of surplus funds on August 25, 2025, without requiring shareholder meeting approval [7][8] - The sponsor institution has confirmed that the decisions made are prudent and do not adversely affect the company's normal operations or shareholder interests [8]

Group 1 - The core viewpoint of the article is that Zhejiang Shuangyuan Technology Co., Ltd. has decided to postpone the expected completion dates of certain fundraising projects while maintaining the original investment purposes and amounts [1][4][5] - The total amount of funds raised by the company is RMB 1,478.57 million, with a net amount of RMB 1,666.36 million allocated for investment projects [2][4] - The company plans to adjust the expected completion dates for the "Intelligent Measurement and Control Equipment Production Base Project" and the "Research and Development Center Project" due to delays caused by various uncontrollable factors [2][4] Group 2 - The company will adhere to relevant regulations and strengthen the supervision and management of the use of raised funds to ensure their legal and effective use [3][4] - The postponement of the fundraising projects is a cautious decision that does not change the project implementation subjects, methods, or investment purposes, and will not have a significant adverse impact on the company's normal operations [4][5] - The board of directors and the supervisory board have approved the postponement of the projects, and this decision does not require submission to the shareholders' meeting for approval [5][6]